Biocardia Inc (BCDA) Stock Analysis

Biocardia Inc (BCDA) is a publicly traded company in the HEALTHCARE sector. It trades at $0.92, carries a market capitalization of $10.46M. This page summarizes the public market data, fundamentals, and frequently asked questions for BCDA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.92
• Market Cap: $10.46M
• EPS: $-0.85
• 52-Week High: $2.45
• 52-Week Low: $0.84

Market Sentiment

Biocardia Inc currently has a Bullish sentiment score of 0.47.

About Biocardia Inc

Biocardia, Inc. is a clinical-stage regenerative medicine company headquartered in San Carlos, California, specializing in innovative therapies for cardiovascular diseases. The company focuses on developing advanced cellular therapies and delivery systems designed to enhance patient outcomes in heart conditions, addressing significant unmet medical needs. With a robust pipeline and a commitment to leveraging cutting-edge technologies, Biocardia is strategically positioned for growth as it app...

GNG Research Analysis

GNG Research scores Biocardia Inc (BCDA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BCDA.

Frequently Asked Questions

Does BCDA pay dividends?

Biocardia Inc (BCDA) does not currently pay a regular dividend.

What is BCDA's market cap?

Biocardia Inc (BCDA) has a market capitalization of $10.46M with a current stock price of $0.92.